Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Core Scientific, Inc. (NASDAQ:CORZ - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 628,246 shares of the company's stock, valued at approximately $8,827,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.22% of Core Scientific as of its most recent SEC filing.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Wellington Shields & Co. LLC purchased a new stake in shares of Core Scientific during the 4th quarter valued at about $26,000. First Horizon Advisors Inc. bought a new position in Core Scientific during the fourth quarter valued at approximately $34,000. Newbridge Financial Services Group Inc. purchased a new stake in Core Scientific in the fourth quarter worth approximately $42,000. Vestcor Inc bought a new stake in Core Scientific in the 4th quarter worth approximately $66,000. Finally, US Bancorp DE bought a new stake in Core Scientific in the 4th quarter worth approximately $99,000.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on CORZ shares. Citizens Jmp raised Core Scientific to a "strong-buy" rating and set a $15.00 price target on the stock in a report on Thursday, May 22nd. Citigroup started coverage on Core Scientific in a research report on Thursday, May 22nd. They set an "outperform" rating for the company. JMP Securities assumed coverage on Core Scientific in a research report on Thursday, May 22nd. They issued a "market outperform" rating and a $15.00 target price on the stock. Canaccord Genuity Group restated a "buy" rating and set a $17.00 price target on shares of Core Scientific in a research note on Friday, May 9th. Finally, Compass Point lowered their price objective on shares of Core Scientific from $26.00 to $20.00 and set a "buy" rating on the stock in a research note on Tuesday, February 25th. Eighteen research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $18.33.
Check Out Our Latest Analysis on CORZ
Core Scientific Stock Performance
Shares of Core Scientific stock traded up $0.28 during trading hours on Monday, hitting $10.93. The company's stock had a trading volume of 7,606,135 shares, compared to its average volume of 13,391,132. The company has a market cap of $3.26 billion, a PE ratio of -2.02 and a beta of 6.66. The business has a 50 day moving average price of $8.55 and a two-hundred day moving average price of $11.63. Core Scientific, Inc. has a 12-month low of $4.74 and a 12-month high of $18.63.
Core Scientific (NASDAQ:CORZ - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.02. The business had revenue of $79.53 million for the quarter, compared to the consensus estimate of $92.04 million. During the same period last year, the business posted $0.78 EPS. The firm's revenue for the quarter was down 55.6% compared to the same quarter last year. As a group, research analysts anticipate that Core Scientific, Inc. will post 0.52 earnings per share for the current year.
Insider Activity
In related news, Director Jordan Levy acquired 62,500 shares of the company's stock in a transaction on Thursday, March 6th. The stock was acquired at an average price of $8.01 per share, with a total value of $500,625.00. Following the acquisition, the director now directly owns 306,887 shares of the company's stock, valued at approximately $2,458,164.87. This trade represents a 25.57% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, Director Yadin Rozov acquired 110,000 shares of the business's stock in a transaction dated Wednesday, May 28th. The shares were purchased at an average price of $10.87 per share, with a total value of $1,195,700.00. Following the transaction, the director now owns 475,687 shares of the company's stock, valued at approximately $5,170,717.69. This represents a 30.08% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 1.40% of the company's stock.
About Core Scientific
(
Free Report)
Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
See Also
Before you consider Core Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.
While Core Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
